Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
Preliminary Clinical Observations on 35 kDa Low-Molecular-Weight Hyaluronan (HA35) in Influenza Prevention and Symptom Control: A Case Series
Authored by
Jessica H. Hui
Hynaut Laboratories (Formerly Amprotein Inc.), Hynaut Group, Qingdao, China.
Xinyue Ma
Hynaut Laboratories (Formerly Amprotein Inc.), Hynaut Group, Qingdao, China.
Xiaoxiao Jia
Hynaut Laboratories (Formerly Amprotein Inc.), Hynaut Group, Qingdao, China.
Mizhou Hui
Hynaut Laboratories (Formerly Amprotein Inc.), Hynaut Group, Qingdao, China.
Li Liu
Far East Hospital, Harbin, China.